Stefan Andersson-Engels

Professor of Physics 
Lund University Medical Laser Centre

Address: Department of Physics, Lund Institute of Technology

Visiting address: Professorsgatan 1,  Lund, Room A427

Post address: P.O. Box 118, SE-221 00 Lund, Sweden


Telephone: +46 (0)46 - 222 31 21

Fax: +46 (0)46 222 42 50


      Link to Medical Laser Physics group presentation

      My CV (54 kB)
      I presently hold a staff position at Division of Atomic Physics, Lund Institute of Technology in Sweden
      My research is performed within the frame of the Lund University Medical Laser Centre
      The Medical Laser Centre is part of the wider Lund Laser Centre
      I am giving two courses at the undergraduate level. One is in Photonics and Optical Communication
      The other course is Tissue Optics
      I have also been heavily involved in a few EC projects

      I am coorganizing a biannual summer school on biophotonics together with Dr. Peter Andersen at Ris National Laboratory in Denmark

Research interests

My research interests are within biomedical and pharmaceutical laser spectroscopy applications. The main focus is tumour detection, localisation or delineation of diseased regions, but also for measurements of physiological properties tissue and quantification of active substances in pharmaceutical preparations. The techniques developed and evaluated in clinical studies and laboratory experiments are fluorescence, Raman and NIR spectroscopy. The clinical applications of this research could be demarcation of malignant tumours in the skin, oral or laryngeal regions, in the urinary bladder, in the brain or in the gastrointestinal tract. Another application is detection of tissue alterations in the cardiovascular region, such as atherosclerotic plaques and a rejected organ following heart transplantation. A second major part of my research is the development and evaluation methods for laser treatments of diseases. Photodynamic therapy and laser thermotherapy are the techniques. Interstitial delivery of light is developed. Especially, the possibility to use the treatment fibres to also monitor the progress of the treatment is investigated. Here, I am mainly interested in treating skin tumours and thicker tumours, which might be difficult to treat with any other method. Another application is the treatment of benign prostatic hyperplasia.

Stefan Andersson-Engels